Timpani Capital Management’s Inspire Medical Systems INSP Stock Holding History

Timpani Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.63M	Buy	+28,766	New	+$1.55M	0.78%	50

Other funds holding INSP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Timpani Capital Management's INSP Position: Q1 2019 in Review

Timpani Capital Management opened a new position in Inspire Medical Systems (INSP) in Q1 2019: 28,766 shares worth $1.63M. The stake represents 0.78% of the portfolio and ranks #50 among its holdings.

143 funds tracked by Wall St. Rank hold INSP as of Q1 2019.

Timpani Capital Management held 28,766 shares of Inspire Medical Systems worth $1.63M as of Q1 2019.
Inspire Medical Systems was a new Timpani Capital Management position in Q1 2019.
Inspire Medical Systems made up 0.78% of Timpani Capital Management's portfolio in Q1 2019, its #50 holding.
143 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2019.

Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.